The decision comes as Schumer is now the Senate’s #2 recipient of pharmaceutical industry campaign cash.
By David Sirota, The Lever
Senate Majority Leader Chuck Schumer (D-N.Y.) let a U.S. Senate adviser kill key parts of Democrats’ promised drug pricing legislation, as Schumer has become the Senate’s second largest recipient of pharmaceutical industry cash.
On Saturday, the Senate’s parliamentary adviser Elizabeth MacDonough — who Schumer can remove — issued a non-binding advisory opinion saying Democrats should remove provisions in their spending bill that would punish drugmakers for inflating their prices for patients in private health insurance plans. The provision could have saved $40 billion, according to one estimate.
“The exclusion of the private insurance price limits means there is little left that will reduce costs for the vast majority of Americans who receive health insurance through their private sector employer,” reported Politico.
MacDonough also advised Democrats against including a provision in their legislation to cap out-of-pocket insulin costs at $35 a month for people on private insurance plans. Democrats ultimately held a failed vote to overrule her on the insulin cap.
Recent Posts
This Is How Starvation Feels In Gaza
Take Action Now In Gaza, many of us have come to fear the forced starvation that Israel is inflicting on us more than its bombs.By Shahad Ali,…
Trump’s Trade Policies Will Hurt Working People Everywhere
Take Action Now America’s trade deficit is a measure of the profligacy of America’s corporate ruling class, more specifically the result of…
Rutgers Senate Proposes Big Ten ‘Mutual Defense Compact’ To Block Trump’s Campus Attacks
Take Action Now Universities “should be embodying the values of democracy,” said one supporter. “And it really becomes clear in…
Democrats And “Free Speech” Warriors Shrug As Trump Deports Dissidents
Take Action Now While the Trump administration targets hundreds over their constitutionally protected right to political speech, Democratic…